These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19697833)

  • 1. [Biochemical mechanisms in the pathogeny of diabetic retinopathy].
    Zamfir C
    Oftalmologia; 2009; 53(2):8-12. PubMed ID: 19697833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
    Wan TT; Li XF; Sun YM; Li YB; Su Y
    Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of oxidative stress in progression of diabetic retinopathy.
    Behl T; Kaur I; Kotwani A
    Surv Ophthalmol; 2016; 61(2):187-96. PubMed ID: 26074354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
    Ola MS; Nawaz MI; Siddiquei MM; Al-Amro S; Abu El-Asrar AM
    J Diabetes Complications; 2012; 26(1):56-64. PubMed ID: 22226482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy--biomolecules and multiple pathophysiology.
    Ahsan H
    Diabetes Metab Syndr; 2015; 9(1):51-4. PubMed ID: 25450817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy.
    Satari M; Aghadavod E; Mobini M; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):8522-8532. PubMed ID: 30478922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trends in drug development for diabetic retinopathy].
    Nishikawa T; Goto H; Sada K; Kukidome D; Araki E
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():369-73. PubMed ID: 23156421
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polyol-, hexosamine pathway and protein C kinase activation in the pathogenesis of diabetic complications].
    Maruyama I
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():227-30. PubMed ID: 23156398
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular mechanism of diabetic angiopathy].
    Watanabe T; Yonekura H; Yamamoto Y; Sakurai S; Yamamoto H
    Seikagaku; 2003 Oct; 75(10):1361-70. PubMed ID: 14635527
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of hyperglycemia in the development of diabetic microangiopathy].
    Miyata S; Kasuga M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():45-51. PubMed ID: 15999684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular understanding of adverse effects of hyperglycemia in diabetic nephropathy].
    Koya D
    Nihon Jinzo Gakkai Shi; 2007; 49(5):470-3. PubMed ID: 17695806
    [No Abstract]   [Full Text] [Related]  

  • 13. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy.
    Wu MY; Yiang GT; Lai TT; Li CJ
    Oxid Med Cell Longev; 2018; 2018():3420187. PubMed ID: 30254714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species].
    Nishikawa T; Araki E
    Rinsho Byori; 2008 Aug; 56(8):712-9. PubMed ID: 18800628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of advanced glycation end products and activation of PKC in diabetic retinopathy].
    Kaji Y; Oshika T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():188-93. PubMed ID: 15999705
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
    Xu Y; He Z; King GL
    Curr Diab Rep; 2005 Apr; 5(2):91-7. PubMed ID: 15794910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic retinopathy and atherosclerosis: is there a link?
    Ellis TP; Choudhury RH; Kaul K; Chopra M; Kohner EM; Tarr JM; Chibber R
    Curr Diabetes Rev; 2013 Mar; 9(2):146-60. PubMed ID: 23094754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation.
    Du XL; Edelstein D; Rossetti L; Fantus IG; Goldberg H; Ziyadeh F; Wu J; Brownlee M
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12222-6. PubMed ID: 11050244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.